Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 6, 2020

Primary Completion Date

October 11, 2021

Study Completion Date

October 11, 2021

Conditions
Opioid-use Disorder
Interventions
BEHAVIORAL

Reminders messages to improve adherence.

"If the participant does not take their medicine at the correct time, a light on the smart pill cap begins to flash. If the bottle is not opened within 20 minutes, the Pillsy application sends an SMS text reminder to the participant's phone. If the bottle is not opened within 60 minutes, the participant receives an automated phone call. The participant may also receive brief motivational phrases or craving surveys that can be tailored to participant needs and preferences. Also, based on pre-populated and adjustable craving and withdrawal levels, the participants' provider could be contacted automatically based on the thresholds being crossed. Pillsy also includes a Pillsy Helpers feature in which the patient can name friends and family members who will also receive a text message notification one hour after a missed dose."

Trial Locations (1)

99202

Washington State University, Spokane

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Washington State University

OTHER

NCT04656899 - Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study | Biotech Hunter | Biotech Hunter